Stories

Operating a vape shop was rewarding in helping individuals quit smoking, like veteran Bob. Despite VA discouragement, Bob and fellow vets found success with vaping. Misinformation led some back to smoking, showcasing the need for accurate guidance. Advocating harm reduction, especially through vaping, could significantly benefit veterans. Bob's story, reflecting many others', emphasizes the necessity for tailored smoking cessation support. Tragically, Bob's health declined after reverting to smoking, underscoring the importance of effective interventions. Sharing such narratives is crucial for shifting perceptions and promoting harm reduction strategies.

The Philippine Smoke-Free Movement urges lawmakers to reconsider the Vape Regulation Law after a vape-related death. A 22-year-old athlete died from e-cigarette use, highlighting the risks of vaping. Concerns include the rise of youth vaping addiction and the failure to protect young people’s health. Advocates call for a review of Republic Act 11900 to reinstate an age restriction of 21 for e-cigarette sales and use.

New e-cigarettes may contain nicotine-like chemicals with unknown impacts on our health, Yale scientists have warned. Despite interacting with the same receptors in our brains, these chemicals—called nicotine analogs—are not held to the same FDA restrictions and scrutiny as other nicotine products, allowing them to be marketed with "youth-appealing flavors" and avoid tobacco taxes. An FDA spokesperson has said that the new chemicals may be even more potent than nicotine, with potential impacts on adolescent brain development, learning and memory.

New research indicates that switching from smoking to vaping doesn't prevent harmful genetic changes. A study comparing young adult vapers and smokers found similar cancer-related gene alterations in both groups, raising concerns for public health and tobacco regulations. The study discovered differential DNA methylation regions in both vapers and smokers, including changes in a gene linked to lung cancer. Researchers emphasize that e-cigarettes are not as safe as believed, with potential disease development risks. The study, led by Stella Tommasi from the University of Southern California, sheds light on the need for further research into the impact of vaping on health.

The Nose Knows AT5000 is a new nasal vaping product by Vozol. Promising intense aroma and quick nicotine absorption, it offers 12 flavors and 5000 puffs. Marketed as a unique sensory experience, it leverages olfactory nerves for satisfaction. Though linked to nasal sprays and snuff, its benefits are debated. While some may find it useful for medical reasons, others question bypassing taste buds. Despite claims of energy boosts, safety remains a concern amid the trend of nasal inhalers. Pre-orders are available, but skepticism lingers over the concept's practicality and appeal, leaving opinions divided on this innovative, yet divisive, vaping approach.

The research explores the impact of different perceptions of nicotine harm on smoking behavior and public health through an Agent-Based Population Model. Different nicotine perception scenarios were simulated based on responses from the PATH Study, affecting smoking rates and mortality predictions until 2100. The study analyzes switching rates to non-combustible products based on perceptions of nicotine harm and models population health impacts. The model considers various transition probabilities, mortality rates, and population dynamics to project outcomes. By comparing base case and perception scenarios, researchers assess the effects of changing attitudes towards nicotine on smoking prevalence and mortality rates among adults.

In March, Inga-Lill Askersjö submitted a report to Sweden's Minister of Social Affairs regarding harm reduction strategies for nicotine products. The report suggests limiting nicotine content in pouches, measuring nicotine per gram, and creating nicotine-free schools. However, these proposals could limit access for adults and reduce the effectiveness of nicotine pouches for smoking cessation. The report overlooks harm reduction benefits and could increase the appeal of nicotine among minors.

British adults using e-cigarettes are at their highest level since 2017, with smokers turning to vapes nearly doubling in three years. Vaping is seen as less harmful but not risk-free, recommended solely as a smoking cessation aid. Action on Smoking and Health reveals that 11% of British adults vape, 53% being former smokers. The Tobacco and Vapes Bill aims to regulate vaping, protecting youths and promoting smoking cessation. Tougher regulations are advised to prevent youth vaping without discouraging adult smoking cessation efforts. Investment in stop smoking services is crucial to support smokers to quit successfully. Perception of vaping harm varies among smokers and non-smokers.

We delve into the key insights and discussions from the Global Forum on Nicotine (GFN). Our expert speakers share their experiences and reflections on the evolution of tobacco harm reduction, exploring the intersection of science, economics, and politics. Learn about the challenges faced, the progress made, and the future of tobacco harm reduction in public health.

The NSW Parliamentary report on vaping fails to address the potential harm reduction benefits for adult smokers. It emphasizes exaggerated fears of youth vaping, dismissing evidence that most young vapers do not become regular users or transition to smoking. The report overlooks the proven benefits of vaping as a quitting aid, opting for ineffective crackdowns on illicit vapes instead of regulated sales. By succumbing to moral panic, the report misses the opportunity to improve public health and protect smokers. A rethink towards evidence-based harm reduction is crucial.